annual book value:
$44.05B-$2.62B(-5.62%)Summary
- As of today (April 12, 2025), NVS annual book value is $44.05 billion, with the most recent change of -$2.62 billion (-5.62%) on December 31, 2024.
- During the last 3 years, NVS annual book value has fallen by -$23.61 billion (-34.90%).
- NVS annual book value is now -43.97% below its all-time high of $78.61 billion, reached on December 31, 2018.
Performance
NVS Book value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly book value:
$44.05B+$729.00M(+1.68%)Summary
- As of today (April 12, 2025), NVS quarterly book value is $44.05 billion, with the most recent change of +$729.00 million (+1.68%) on December 31, 2024.
- Over the past year, NVS quarterly book value has stayed the same.
- NVS quarterly book value is now -44.08% below its all-time high of $78.76 billion, reached on June 30, 2015.
Performance
NVS quarterly book value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Book value Formula
Book Value = Total Assets − Total Liabilities
NVS Book value Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.6% | 0.0% |
| 3 y3 years | -34.9% | 0.0% |
| 5 y5 years | -20.6% | 0.0% |
NVS Book value Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -34.9% | at low | -30.0% | +15.4% |
| 5 y | 5-year | -34.9% | at low | -34.9% | +15.4% |
| alltime | all time | -44.0% | +93.0% | -44.1% | +114.3% |
Novartis AG Book value History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $44.05B(-5.6%) | $44.05B(+1.7%) |
| Sep 2024 | - | $43.32B(+3.8%) |
| Jun 2024 | - | $41.73B(+5.2%) |
| Mar 2024 | - | $39.67B(-15.0%) |
| Dec 2023 | $46.67B(-21.4%) | $46.67B(+22.3%) |
| Sep 2023 | - | $38.16B(-26.4%) |
| Jun 2023 | - | $51.85B(-0.4%) |
| Mar 2023 | - | $52.06B(-12.3%) |
| Dec 2022 | $59.34B(-12.3%) | $59.34B(-2.4%) |
| Sep 2022 | - | $60.82B(-3.3%) |
| Jun 2022 | - | $62.92B(+2.3%) |
| Mar 2022 | - | $61.54B(-9.0%) |
| Dec 2021 | $67.66B(+19.5%) | $67.66B(+19.2%) |
| Sep 2021 | - | $56.77B(+5.0%) |
| Jun 2021 | - | $54.04B(+7.0%) |
| Mar 2021 | - | $50.52B(-10.7%) |
| Dec 2020 | $56.60B(+2.0%) | $56.60B(+3.9%) |
| Sep 2020 | - | $54.48B(+1.2%) |
| Jun 2020 | - | $53.81B(+5.7%) |
| Mar 2020 | - | $50.90B(-8.2%) |
| Dec 2019 | $55.47B(-29.4%) | $55.47B(+5.6%) |
| Sep 2019 | - | $52.52B(+2.1%) |
| Jun 2019 | - | $51.43B(+8.9%) |
| Mar 2019 | - | $47.23B(-39.9%) |
| Dec 2018 | $78.61B(+6.0%) | $78.61B(+0.9%) |
| Sep 2018 | - | $77.94B(+1.5%) |
| Jun 2018 | - | $76.81B(+8.0%) |
| Mar 2018 | - | $71.10B(-4.1%) |
| Dec 2017 | $74.17B(-0.9%) | $74.17B(+2.6%) |
| Sep 2017 | - | $72.31B(+3.4%) |
| Jun 2017 | - | $69.92B(+3.5%) |
| Mar 2017 | - | $67.59B(-9.7%) |
| Dec 2016 | $74.83B(-2.9%) | $74.83B(-0.2%) |
| Sep 2016 | - | $74.98B(+3.5%) |
| Jun 2016 | - | $72.46B(+0.9%) |
| Mar 2016 | - | $71.81B(-6.8%) |
| Dec 2015 | $77.05B(+8.9%) | $77.05B(+0.4%) |
| Sep 2015 | - | $76.71B(-2.6%) |
| Jun 2015 | - | $78.76B(+3.1%) |
| Mar 2015 | - | $76.38B(+7.9%) |
| Dec 2014 | $70.77B(-4.8%) | $70.77B(-0.8%) |
| Sep 2014 | - | $71.34B(+1.4%) |
| Jun 2014 | - | $70.39B(+0.3%) |
| Mar 2014 | - | $70.21B(-5.6%) |
| Dec 2013 | $74.34B(+7.5%) | $74.34B(+3.2%) |
| Sep 2013 | - | $72.05B(+3.7%) |
| Jun 2013 | - | $69.49B(+3.7%) |
| Mar 2013 | - | $67.03B(-3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $69.14B(+5.0%) | $69.14B(+3.1%) |
| Sep 2012 | - | $67.08B(+4.6%) |
| Jun 2012 | - | $64.13B(+1.6%) |
| Mar 2012 | - | $63.10B(-4.2%) |
| Dec 2011 | $65.84B(+4.2%) | $65.84B(-0.4%) |
| Sep 2011 | - | $66.14B(-1.4%) |
| Jun 2011 | - | $67.09B(+2.7%) |
| Mar 2011 | - | $65.34B(+3.4%) |
| Dec 2010 | $63.20B(+10.1%) | $63.20B(-4.6%) |
| Sep 2010 | - | $66.22B(+18.6%) |
| Jun 2010 | - | $55.82B(+1.1%) |
| Mar 2010 | - | $55.22B(-3.8%) |
| Dec 2009 | $57.39B(+14.1%) | $57.39B(+7.6%) |
| Sep 2009 | - | $53.31B(+5.6%) |
| Jun 2009 | - | $50.49B(+9.2%) |
| Mar 2009 | - | $46.23B(-8.1%) |
| Dec 2008 | $50.29B(+2.2%) | $50.29B(-0.9%) |
| Sep 2008 | - | $50.74B(-1.7%) |
| Jun 2008 | - | $51.60B(+4.7%) |
| Mar 2008 | - | $49.27B(+0.1%) |
| Dec 2007 | $49.22B(+19.7%) | $49.22B(-0.5%) |
| Sep 2007 | - | $49.49B(+13.3%) |
| Jun 2007 | - | $43.66B(+7.8%) |
| Mar 2007 | - | $40.50B(-1.5%) |
| Dec 2006 | $41.11B(+24.6%) | $41.11B(+6.5%) |
| Sep 2006 | - | $38.59B(+3.8%) |
| Jun 2006 | - | $37.16B(+10.1%) |
| Mar 2006 | - | $33.75B(+2.3%) |
| Dec 2005 | $32.99B(+5.8%) | $32.99B(+3.9%) |
| Sep 2005 | - | $31.74B(+4.4%) |
| Jun 2005 | - | $30.39B(+3.2%) |
| Mar 2005 | - | $29.46B(-5.5%) |
| Dec 2004 | $31.18B(+2.5%) | $31.18B(+0.6%) |
| Sep 2004 | - | $30.99B(+2.8%) |
| Jun 2004 | - | $30.16B(+2.8%) |
| Mar 2004 | - | $29.32B(-3.6%) |
| Dec 2003 | $30.43B(+7.6%) | $30.43B(+7.0%) |
| Sep 2003 | - | $28.44B(+7.7%) |
| Jun 2003 | - | $26.42B(-5.7%) |
| Mar 2003 | - | $28.01B(-0.9%) |
| Dec 2002 | $28.27B(+10.9%) | $28.27B(+9.3%) |
| Sep 2002 | - | $25.87B(-7.4%) |
| Jun 2002 | - | $27.94B(+9.6%) |
| Dec 2001 | $25.50B(+11.6%) | $25.50B(+24.1%) |
| Jun 2001 | - | $20.55B(-10.0%) |
| Dec 2000 | $22.84B(-2.3%) | $22.84B(-1.4%) |
| Jun 2000 | - | $23.16B |
| Dec 1999 | $23.37B(+2.4%) | - |
| Dec 1998 | $22.82B | - |
FAQ
- What is Novartis AG annual book value?
- What is the all time high annual book value for Novartis AG?
- What is Novartis AG annual book value year-on-year change?
- What is Novartis AG quarterly book value?
- What is the all time high quarterly book value for Novartis AG?
- What is Novartis AG quarterly book value year-on-year change?
What is Novartis AG annual book value?
The current annual book value of NVS is $44.05B
What is the all time high annual book value for Novartis AG?
Novartis AG all-time high annual book value is $78.61B
What is Novartis AG annual book value year-on-year change?
Over the past year, NVS annual book value has changed by -$2.62B (-5.62%)
What is Novartis AG quarterly book value?
The current quarterly book value of NVS is $44.05B
What is the all time high quarterly book value for Novartis AG?
Novartis AG all-time high quarterly book value is $78.76B
What is Novartis AG quarterly book value year-on-year change?
Over the past year, NVS quarterly book value has changed by $0.00 (0.00%)